(MENAFN- PR Newswire)
FORNEBU, Norway, March 7, 2025 /PRNewswire/ -- An extraordinary general meeting of Aker Carbon Capture ASA (the "Company") was held today as a digital meeting with online participation. All resolutions were made in accordance with the proposals set out in the meeting notice, including the proposed share capital reduction and the proposed dividend of NOK 5.80 per share divided as follows:
NOK 4.82 per share shall be paid to the Company's shareholders as of 7 March 2025 (as registered in the VPS as of 11 March 2025), and
NOK 0.98 per share shall be paid to the Company's shareholders as of 25 April 2025 (as registered in the VPS as of 29 April 2025) or such other dates which are decided and communicated by the board, subject however to completion of the capital reduction.
The creditor notice period for the share capital reduction is expected to commence on or about 10 March 2025 and expected to expire on or about 22 April.
The minutes of the meeting are attached to this announcement and available on the Company's website .
For further information:
Media and Investors: Mats Ektvedt, mobile: +47 41 42 33 28,
e-mail: [email protected]
This information is subject to disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
This information was brought to you by Cision
,c4116101
The following files are available for download:
| |
ACC - Minutes of EGM - 7 March 2025 |
SOURCE Aker Carbon Capture ASA
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
GET STARTED
MENAFN07032025003732001241ID1109288877
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment